Literature DB >> 21742100

Resting cardiac energy metabolism is inversely associated with heart rate in healthy young adult men.

Gabriele Fragasso1, Francesco De Cobelli, Roberto Spoladore, Antonio Esposito, Anna Salerno, Giliola Calori, Claudia Montanaro, Francesco Maranta, Guido Lattuada, Alberto Margonato, Alessandro Del Maschio, Gianluca Perseghin.   

Abstract

BACKGROUND: 31-Phosphorus-magnetic resonance spectroscopy may provide pathophysiological insights into the high-energy phosphate metabolism of the myocardium as measured by phosphocreatine to adenosine triphosphate (PCr/ATP) ratio. Aim of the present study was to determine in vivo the relation between cardiac PCr/ATP ratio and heart rate in normal male subjects.
METHODS: One hundred twelve apparently healthy, young male individuals (age 34 ± 10 years) were prospectively evaluated. They underwent cardiac cine magnetic resonance imaging to assess left ventricular (LV) function and morphology and 3D-ISIS (31)P-magnetic resonance spectroscopy of the LV to assess the PCr/ATP ratio (a recognized in vivo marker of myocardial energy metabolism). Data were analyzed after segregation by tertiles of the resting PCr/ATP ratio.
RESULTS: A significant inverse association between PCr/ATP ratios and resting heart rate was observed (Spearman ρ: r=-0.37; P < .0001). PCr/ATP ratios were also inversely associated with body mass index, diastolic blood pressure, wall mass and with insulin resistance, but in multiple regression analysis heart rate was found to be independently related to PCr/ATP.
CONCLUSIONS: The present study shows that resting heart rate is proportionally lower across tertiles of increasing PCr/ATP ratio of the LV in apparently healthy young male individuals, supporting the hypothesis that heart rate is a major determinant of cardiac energy stores. These findings may explain the prognostic role of heart rate in the general population as evidenced by previous large epidemiological studies.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742100     DOI: 10.1016/j.ahj.2011.04.012

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

Review 1.  New medications for heart failure.

Authors:  Jonathan S Gordin; Gregg C Fonarow
Journal:  Trends Cardiovasc Med       Date:  2016-03-03       Impact factor: 6.677

2.  In vivo mouse myocardial (31)P MRS using three-dimensional image-selected in vivo spectroscopy (3D ISIS): technical considerations and biochemical validations.

Authors:  Adrianus J Bakermans; Desiree Abdurrachim; Bastiaan J van Nierop; Anneke Koeman; Inge van der Kroon; Antonius Baartscheer; Cees A Schumacher; Gustav J Strijkers; Sander M Houten; Coert J Zuurbier; Klaas Nicolay; Jeanine J Prompers
Journal:  NMR Biomed       Date:  2015-08-13       Impact factor: 4.044

Review 3.  Ivabradine in Cardiovascular Disease Management Revisited: a Review.

Authors:  Christopher Chen; Gurleen Kaur; Puja K Mehta; Doralisa Morrone; Lucas C Godoy; Sripal Bangalore; Mandeep S Sidhu
Journal:  Cardiovasc Drugs Ther       Date:  2021-01-07       Impact factor: 3.727

4.  Impact of age on the association between cardiac high-energy phosphate metabolism and cardiac power in women.

Authors:  Maria Nathania; Kieren G Hollingsworth; Matthew Bates; Christopher Eggett; Michael I Trenell; Lazar Velicki; Petar M Seferovic; Guy A MacGowan; Doug M Turnbull; Djordje G Jakovljevic
Journal:  Heart       Date:  2017-06-12       Impact factor: 5.994

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.